Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,67 USD | +1,21% | -4,02% | +4,38% |
Attività
Numero di dipendenti: 8
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Niall O'Donnell
FOU | Founder | 51 | - |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Jennifer P. Lam
ADM | Chief Administrative Officer | - | 01/08/21 |
Michael Cruse
COO | Chief Operating Officer | 52 | 01/12/20 |
Chief Tech/Sci/R&D Officer | 64 | 01/01/18 | |
Ashley Hall
PRN | Corporate Officer/Principal | 52 | 11/10/21 |
Corporate Officer/Principal | - | 01/01/18 | |
Wendy Johnson
PRN | Corporate Officer/Principal | 72 | 01/01/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Grey
FOU | Founder | 71 | 22/09/14 |
Director/Board Member | 64 | 01/12/17 | |
Paul Hoelscher
BRD | Director/Board Member | 59 | 20/01/22 |
Gregory Flesher
CEO | Chief Executive Officer | 54 | 09/12/20 |
Stacey Seltzer
BRD | Director/Board Member | 47 | 01/12/20 |
Niall O'Donnell
FOU | Founder | 51 | - |
Bali Muralidhar
BRD | Director/Board Member | 44 | 01/04/21 |
Roshawn Blunt
BRD | Director/Board Member | 49 | 01/01/22 |
Eric Dube
BRD | Director/Board Member | 51 | 15/03/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 33 420 808 | 32 416 707 ( 97,00 %) | 0 | 97,00 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+4,38% | 55,81 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione RPHM
- Società Reneo Pharmaceuticals, Inc.